Molnupiravir will not replace vaccines but reduce transmission

Added aid to curb virus: Molnupiravir is able to reduce 50% of hospital admissions and is effective against more infectious variants of Covid-19 including Gamma, Delta and Mu, says a research. — Reuters

PETALING JAYA: The antiviral drug Molnupiravir will not replace vaccines but will offer an alternative in treating Covid-19 patients, health experts have pointed out.

Universiti Malaya epidemiologist Prof Datuk Dr Awang Bulgiba Awang Mahmud said the drug could reduce transmission in patients.